Renal physiology

CHF Solutions’ Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients

Retrieved on: 
Thursday, January 28, 2021
Natural sciences, Membrane technology, Renal physiology, Ultrafiltration

Early application of ultrafiltration with Aquadex could improve patients outcomes sooner and quality of life (i.e., reduce hospital length of stay).

Key Points: 
  • Early application of ultrafiltration with Aquadex could improve patients outcomes sooner and quality of life (i.e., reduce hospital length of stay).
  • Ultrafiltration continues to be an effective solution for heart failure patients as demonstrated by the decade of experience included in the study conducted by the phenomenal team at Abington-Jefferson, saidNestor Jaramillo, Jr., President and CEO ofCHF Solutions.
  • CHF Solutions does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
  • CONTACTS INVESTORS: Claudia Napal Drayton Chief Financial Officer, CHF Solutions, Inc. 952-345-4205 [email protected] Matt Bacso, CFA Gilmartin Group LLC [email protected] MEDIA: Jessica Stebing Health+Commerce 260-336-6202 [email protected]

Albumin & Creatinine Tests Market by Product, Type and End-user - Global Forecast to 2025

Retrieved on: 
Tuesday, January 26, 2021
Branches of biology, Renal physiology, Blood proteins, Albuminuria, Creatinine, Serum albumin, Anatomy, Blood tests

DUBLIN, Jan. 26, 2021 /PRNewswire/ -- The "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (POC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 26, 2021 /PRNewswire/ -- The "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (POC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global albumin & creatinine tests market size is valued at an estimated USD 987 million in 2020 and is projected to reach USD 2,103 million by 2025, at a CAGR of 16.3% during the forecast period.
  • The dipstick & kits segment accounted for the highest growth rate in the albumin & creatinine tests market, by product, during the forecast period.
  • Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests.

Global Albumin & Creatinine Tests Market (2020 to 2025) - Integrated and Automated Systems for Overall Urine Analysis Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, January 22, 2021
Diabetes, Health, Other Health, Branches of biology, Renal physiology, Blood proteins, Albuminuria, Creatinine, Serum albumin, Biology, Dipstick

The "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (POC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (POC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The dipstick & kits segment accounted for the highest growth rate in the albumin & creatinine tests market, by product, during the forecast period.
  • Based on product, the albumin & creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables.
  • Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests.

Albumin & Creatinine Tests Market worth $2,103 million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, January 14, 2021
Branches of biology, Renal physiology, Blood proteins, Creatinine, Guanidines, Metabolism, Serum albumin, Dipstick, ACR, Biology, Microalbuminuria

The dipsticks & kits products segment accounted for the largest share of the ACR Tests Market, by product segment, in 2019

Key Points: 
  • The dipsticks & kits products segment accounted for the largest share of the ACR Tests Market, by product segment, in 2019
    Based on product, the albumin and creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables.
  • In 2019, the dipsticks & kits segment accounted for the largest share in this market.
  • The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth.
  • Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests.

Albumin & Creatinine Tests Market worth $2,103 million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, January 14, 2021
Branches of biology, Renal physiology, Blood proteins, Creatinine, Guanidines, Metabolism, Serum albumin, Dipstick, ACR, Biology, Microalbuminuria

The dipsticks & kits products segment accounted for the largest share of the ACR Tests Market, by product segment, in 2019

Key Points: 
  • The dipsticks & kits products segment accounted for the largest share of the ACR Tests Market, by product segment, in 2019
    Based on product, the albumin and creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables.
  • In 2019, the dipsticks & kits segment accounted for the largest share in this market.
  • The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth.
  • Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests.

VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)

Retrieved on: 
Monday, December 21, 2020
Health, FDA, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Branches of biology, Medicine, Clinical medicine, Blood tests, Renal physiology, Assessment of kidney function, EGFR, Vifor Pharma, Vasculitis, Epidermal growth factor receptor, Placebo, Epidermal growth factor

We are pleased with the results of the ACCOLADE study, said Stefan Schulze, Chief Executive Officer of Vifor Pharma.

Key Points: 
  • We are pleased with the results of the ACCOLADE study, said Stefan Schulze, Chief Executive Officer of Vifor Pharma.
  • The study further consolidates the effectiveness of avacopan in proliferative glomerular diseases and confirms the evidence of the favourable safety profile of avacopan.
  • The data from this well-controlled, blinded placebo comparison trial provides evidence that avacopan can improve kidney function in C3G.
  • Recall that avacopan also improved kidney function in ANCA-associated vasculitis; here again the ACCOLADE C3G data show a robust and significant increase in eGFR after 26 weeks of therapy.

Global $250+ Million Creatinine Assay Kits Market to 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, December 21, 2020
Other Manufacturing, Manufacturing, Renal physiology, Creatinine, Guanidines, Metabolism, Compound annual growth rate, Academic disciplines

The "Creatinine Assay Kits - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Creatinine Assay Kits - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Creatinine Assay Kits estimated at US$203.7 Million in the year 2020, is projected to reach a revised size of US$266.1 Million by 2027, growing at a CAGR of 3.9% over the analysis period 2020-2027.
  • This segment currently accounts for a 32.6% share of the global Creatinine Assay Kits market.
  • The U. S. Accounts for Over 29.4% of Global Market Size in 2020, While China is Forecast to Grow at a 3.6% CAGR for the Period of 2020-2027
    The Creatinine Assay Kits market in the U. S. is estimated at US$59.9 Million in the year 2020.

numares’ Novel Multi-marker Kidney Function Testing Shows Promising Results in US Validation Study

Retrieved on: 
Tuesday, December 15, 2020
Biotechnology, FDA, Managed care, Diabetes, Health, Pharmaceutical, Oncology, Medical devices, Research, Science, Clinical trials, Renal physiology, Branches of biology, Blood tests, Anatomy, Medical specialties, Glomerular filtration rate, Assessment of kidney function, GFR, Cystatin C, Draft:Shrunken pore syndrome

numares today announced that its novel multi-marker approach for the accurate assessment of glomerular filtration rate (GFR) shows promising results in a US based clinical validation study.

Key Points: 
  • numares today announced that its novel multi-marker approach for the accurate assessment of glomerular filtration rate (GFR) shows promising results in a US based clinical validation study.
  • Compared to existing serum-based GFR methods, this multi-marker algorithm more accurately reflects gold-standard invasive clearance testing methods.
  • The validation was performed in a retrospective study using US-based and European clinical data.
  • The outcome of this validation study surpasses the performance of the existing equations that are used to estimate kidney function, says Dr. Volker Pfahlert, Chief Executive Officer of numares.

Calibrating kidney function for cancer patients

Retrieved on: 
Thursday, December 10, 2020
Medical specialties, Clinical medicine, Medicine, Kidney diseases, Assessment of kidney function, Renal physiology, Nephrology, Kidney disease, Kidney, Kidney transplantation

To be sure a treatment reaches tumor cells at the right dose, patients whose kidneys remove compounds from their blood efficiently will need more drug than someone whose kidney function is impaired.

Key Points: 
  • To be sure a treatment reaches tumor cells at the right dose, patients whose kidneys remove compounds from their blood efficiently will need more drug than someone whose kidney function is impaired.
  • Clinicians assess kidney function before every round of cancer treatment.
  • Previous models were developed using data from patients with kidney disease, whose failing kidney function must be closely monitored.
  • "Cancer patients may have a unique physiology, and most of them don't have impaired kidney function.

CHF Solutions Announces Webinar on Pediatric Ultrafiltration Therapy hosted by Ladenburg Thalman & Co.

Retrieved on: 
Friday, December 4, 2020
Natural sciences, Health sciences, Chemistry, Membrane technology, Renal physiology, Ultrafiltration, Filtration, Hypervolemia, Therapy

Eastern Time on Tuesday, December 8, 2020 highlighting pediatric ultrafiltration therapy and the Aquadex SmartFlow System as part of Ladenburg Thalmans LT Healthcare Symposia Series.

Key Points: 
  • Eastern Time on Tuesday, December 8, 2020 highlighting pediatric ultrafiltration therapy and the Aquadex SmartFlow System as part of Ladenburg Thalmans LT Healthcare Symposia Series.
  • CHF Solutions, Inc. (Nasdaq: CHFS) is a medical device company dedicated to improving the lives of patients suffering from fluid overload with its novel ultrafiltration therapy system.
  • The company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow system for ultrafiltration therapy.
  • CHF Solutions does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.